View All HCPCS Sections

• C9355

  Collagen nerve cuff (neuromatrix), per 0.5 centimeter length

• C9356

  Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter

• C9358

  Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters

• C9359

  Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc

• C9360

  Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters

• C9361

  Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length

• C9362

  Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc

• C9363

  Skin substitute, integra meshed bilayer wound matrix, per square centimeter

• C9364

  Porcine implant, permacol, per square centimeter

• C9399

  Unclassified drugs or biologicals

• C9407

  Iodine i-131 iobenguane, diagnostic, 1 millicurie

• C9408

  Iodine i-131 iobenguane, therapeutic, 1 millicurie

• C9441

  Injection, ferric carboxymaltose, 1 mg

• C9442

  Injection, belinostat, 10 mg

• C9443

  Injection, dalbavancin, 10 mg

• C9444

  Injection, oritavancin, 10 mg

• C9445

  Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units

• C9446

  Injection, tedizolid phosphate, 1 mg

• C9447

  Injection, phenylephrine and ketorolac, 4 ml vial

• C9448

  Netupitant 300 mg and palonosetron 0.5 mg, oral

• C9449

  Injection, blinatumomab, 1 mcg

• C9450

  Injection, fluocinolone acetonide intravitreal implant, 0.01 mg

• C9451

  Injection, peramivir, 1 mg

• C9452

  Injection, ceftolozane 50 mg and tazobactam 25 mg

• C9453

  Injection, nivolumab, 1 mg

• C9454

  Injection, pasireotide long acting, 1 mg

• C9455

  Injection, siltuximab, 10 mg

• C9456

  Injection, isavuconazonium sulfate, 1 mg

• C9457

  Injection, sulfur hexafluoride lipid microsphere, per ml

• C9458

  Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries

• C9459

  Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries

• C9460

  Injection, cangrelor, 1 mg

• C9461

  Choline c 11, diagnostic, per study dose

• C9462

  Injection, delafloxacin, 1 mg

• C9463

  Injection, aprepitant, 1 mg

• C9464

  Injection, rolapitant, 0.5 mg

• C9465

  Hyaluronan or derivative, durolane, for intra-articular injection, per dose

• C9466

  Injection, benralizumab, 1 mg

• C9467

  Injection, rituximab and hyaluronidase, 10 mg

• C9468

  Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.

• C9469

  Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

• C9470

  Injection, aripiprazole lauroxil, 1 mg

• C9471

  Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg

• C9472

  Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)

• C9473

  Injection, mepolizumab, 1 mg

• C9474

  Injection, irinotecan liposome, 1 mg

• C9475

  Injection, necitumumab, 1 mg

• C9476

  Injection, daratumumab, 10 mg

• C9477

  Injection, elotuzumab, 1 mg

• C9478

  Injection, sebelipase alfa, 1 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/3/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.